Research, Funding, and Awards

  • 4/16 UConn TIP company, BIOARRAY: A Start-up Story

    UConn TIP company, BIOARRAY: A Start-up Story – Increasing Treatment Success Rates Through Personalized MedicineSponsored by the BioscienceClubhouseCT, CURE – The Bioscience Network of CT

    Come to hear about one of the UConn Technology Incubation Program’s (TIP) successful UCHC companies.  BIOARRAY Therapeutics Inc. (BIOARRAY).  BIOARRAY is developing diagnostic tests to match a breast cancer patient with the right drug the first time. BIOARRAY’s lead test has been shown to reduce ineffective treatments by over 50% in proof of concept studies. Marcia Fournier, who started her company, will talk about how the company is developing the technology from discovery to product development stage, leveraging the study of cancer in reverse, and the experience of partners.

    BIOARRAY is a recipient of Avon Foundation for Women and Connecticut Innovations funds. BIOARRAY was nominated the “Most Promising Life Science Product” by CT Technology Council and is a MassChallenge Accelerator Winner.

    Dr. Fournier, a molecular biologist, is trained in genetics with 10+ years of experience in cancer research. She most recently held a position at GlaxoSmithKline, Oncology Center of Excellence for Drug Discovery. Marcia’s work as a doctoral fellow at the Dana-Farber Institute and postdoctoral fellow at UC Berkeley led to seminal publications on biomarker discovery.

    CURE has recently announced the opening of the CURE Innovation Commons, located in a former Pfizer facility in Groton, CT.  This facility will offer companies that graduate from the TIP program at UConn and other life science ventures an environment for expansion.  

    Date: Wednesday, April 16
    Location: Pfizer Inc, Building 220, Groton, CT 06340

    Time: 4:30 pm - 6:00 pm

    Refreshments will be provided

    Note: Registration required by April 15th – please go to the following site for registering: http://www.eventbrite.com/e/bioarray-a-start-up-story-increasing-treatment-success-rates-through-personalized-medicine-tickets-10989436701

    Submitted by: Technology, Partnerships & Licensing Program, Office of the Vice President for Research

    Contact: fidantsef@uchc.edu

    For more information, contact: Technology, Partnerships and Licensing at fidantsef@uchc.edu